Optical Quality After Implantation of a Spherical or Aspherical Intraocular Lens in Hypermetropic Patients
NCT ID: NCT01995630
Last Updated: 2017-06-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
62 participants
INTERVENTIONAL
2013-11-30
2016-06-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optical Biometry and Spherical Aberration in Ametropic and Emmetropic Eyes
NCT01663597
Photopic and Mesopic Multifocal IOL Performance
NCT06978556
The Purpose is to Evaluate Visual Acuity for Distance, Intermediate and Near and Additionally Contrast Sensitivity at 25% and 10% of Illumination After Implantation of Trifocal IOL, Extended Range of Vision IOL, Bifocal IOL With Low Addition and Monofocal IOL
NCT07008768
Spherical Aberration on the Optical of Two Different Aspherical Intraocular Lenses
NCT03224728
Spherical Aberration and Contrast Sensitivity in IOLs
NCT00576485
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hypermetropic, spherical IOL
AMO Sensar AR40e
AMO Sensar AR40e
Hypermetropic, aspheric IOL
AMO Tecnis ZA9003
AMO Tecnis ZA9003
Emmetropic, spherical IOL
AMO Sensar AR40e
AMO Sensar AR40e
Emmetropic, aspheric IOL
AMO Tecnis ZA9003
AMO Tecnis ZA9003
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AMO Tecnis ZA9003
AMO Sensar AR40e
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Dioptric power of IOL \>22.0 D in hypermetropic patients and 18.0-22.0 D in emmetropic patients, respectively
Exclusion Criteria
* Corneal scarring or irregularities
* Astigmatism \>1.5 D
* Amblyopia
* Perioperative complications
* Postoperative refractive error \>2.0 D of spherical equivalent
* Postoperative DCVA \<0.8 (ETDRS)
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Graz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Navid Ardjomand
Univ.-Doz. Dr. med. univ.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Navid Ardjomand, MD
Role: PRINCIPAL_INVESTIGATOR
Dept. of Ophthalmology, Medical University of Graz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept. of Ophthalmology, Medical University of Graz
Graz, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SIOLvsAIOL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.